Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
0.2827
-0.0072 (-2.48%)
At close: Sep 4, 2025, 4:00 PM
0.2913
+0.0086 (3.04%)
After-hours: Sep 4, 2025, 7:11 PM EDT

Leap Therapeutics Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Leap Therapeutics.

Price Target: $ (0.00%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

According to 1 stock analyst, the rating for Leap Therapeutics is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy111110
Buy000000
Hold111111
Sell000000
Strong Sell000000
Total222221

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
n/a
HoldReiteratesn/an/aMar 27, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
n/a
HoldDowngradesn/an/aJan 29, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5.5
Strong BuyReiterates$5.5+1,845.53%Jan 16, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5.5
Strong BuyReiterates$5.5+1,845.53%Nov 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5.5
Strong BuyReiterates$5.5+1,845.53%Aug 13, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.13
from -1.81
EPS Next Year
-0.54
from -1.13
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.50M1.50M-----
Revenue Growth
-------
EPS
-6.34-4.73-4.82-3.98-1.81-1.13-0.54
EPS Growth
-------
Forward PE
-------
No. Analysts
-----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20252026202720282029
High--
Avg--
Low--

EPS Forecast

EPS20252026202720282029
High-1.17-0.56
Avg-1.13-0.54
Low-1.09-0.52

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.